In response to a lawsuit, the FDA has said that it will reevaluate its previous decision to remove tirzepatide from its ...

The case for Novo Nordisk. Right now Novo Nordisk has a considerable lead on Lilly in GLP-1 market share, and a couple of ...

Rapper Fat Joe recently shared how he’s been using the Type 2 diabetes medication Ozempic to maintain his 200-pound weight ...

The FDA is weighing a decision that could stop compounding pharmacies from legally making cheaper versions of Mounjaro and ...

Medicare coverage of the drugs would up federal spending by $35 billion from 2026 to 2034. Meanwhile, CNBC tests Abbott’s ...

Facing a lawsuit, the Food and Drug Administration has decided to reconsider its decision to take popular weight-loss and diabetes drugs off of the national shortage list, which will allow compounding ...

One of the biggest changes takes effect in 2025. Part D drug plans must cap out-of-pocket spending on covered drugs at $2,000 ...

New weight-loss jabs could help boost the economy in Britain by getting people “back into work”, the Prime Minister has said. Sir Keir Starmer said that the anti-obesity medication could also help ...

A study by Health Innovation Manchester and Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known as tirzepatide, on weight loss, diabetes prevention, the ...

Celebrities like Oprah Winfrey are touting it. People are microdosing it. And, in the midst of a national shortage of key ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The U.S. Food and Drug Administration on Friday agreed to reconsider a decision it made last month to bar drug compounders ...